95 assets in Glioma

Therapeutic assets addressing Glioma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Taselisib Glioma	National Cancer Institute (NCI)	P2	CCC (50)
Copanlisib Glioma	National Cancer Institute (NCI)	P2	CCC (49)
Capmatinib Glioma	Cancer Research UK	P2/3	CCC (48)
Cobolimab Glioma	GlaxoSmithKline	P1/2	CCC (48)
Dostarlimab Glioma	GlaxoSmithKline	P1/2	CCC (48)
Nms-03305293 Glioma	Nerviano Medical Sciences	P1/2	CCC (48)
Rhenium Liposome Treatment Glioma	Plus Therapeutics	P1/2	CCC (48)
Methimazole Glioma	Case Comprehensive Cancer Center	P2	CC (46)
Temsirolimus Glioma	Nader Sanai	P1	CC (44)
Apg-157 Glioma	Aveta Biomics, Inc.	P1/2	CC (43)
Carv3-Team-E T Cells Glioma	Marcela V. Maus, M.D.,Ph.D.	P1	CC (43)
CD19t Glioma	City of Hope Medical Center	P1	CC (43)
Fludarabine Glioma	Essen Biotech	P1/2	CC (43)
Gnc-039 Glioma	Sichuan Baili Pharmaceutical Co., Ltd.	P1	CC (43)
her2bbζ/cd19t+ t cells Glioma	City of Hope Medical Center	P1	CC (43)
HER2(EQ)BBzeta Glioma	City of Hope Medical Center	P1	CC (43)
LMP744 Glioma	National Institute of Neurological Disorders and Stroke (NINDS)	P1/2	CC (43)
L-Tryptophan, 1-(2-(Fluoro-18F)Ethyl)- Glioma	Barbara Ann Karmanos Cancer Institute	P1	CC (43)
Onc 206 Glioma	Jazz Pharmaceuticals	P1	CC (43)
Sulfur Hexafluoride Glioma	NaviFUS Corporation	P1/2	CC (43)
TIL Glioma	Essen Biotech	P1/2	CC (43)
Polyethyleneglycol-7-Ethyl-10-Hydroxycamptothecin Dfp-13318 Glioma	National Cancer Institute (NCI)	P1/2	CC (42)
Ad5-yCD Glioma	Henry Ford Health System	P1	C (39)
ad5-ycd/muttksr39rep-adp adenovirus Glioma	Henry Ford Health System	P1	C (39)
bc008-1a Glioma	Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.	P1	C (39)
Claturafenib Glioma	Pfizer	P1	C (39)
Definity Glioma	Sunnybrook Health Sciences Centre	P1	C (39)
[F-18]MeFAMP Glioma	University of Alabama at Birmingham	Early P1	C (39)
Fluorouracilum Glioma	Pfizer	P1	C (39)
Glix1 Glioma	Tetragon Biosciences Ltd	P1	C (39)
Ketoconazole Glioma	Universitas Padjadjaran	Early P1	C (39)
LY 3410738 Glioma	Eli Lilly and Company	P1	C (39)
Midazolam Glioma	Pfizer	P1	C (39)
Nst-628 Glioma	Nested Therapeutics, Inc	P1	C (39)
Oxaliplatin Glioma	Pfizer	P1	C (39)
pf-07799544 Glioma	Pfizer	P1	C (39)
Rqnestin Glioma	Dana-Farber Cancer Institute	P1	C (39)
Sitagliptin Glioma	Kailin Yang, MD, PhD	P1	C (39)
Vipivotide Tetraxetan Glioma	Memorial Sloan Kettering Cancer Center	P1	C (39)
[177Lu]Lu-HT547 Glioma	Hua Pang	Early P1	C (36)
[⁶⁸Ga]Ga-HT547 Glioma	Hua Pang	Early P1	C (36)
azd1390 Glioma	Nader Sanai	Early P1	C (36)
Cysteine Glioma	UNC Lineberger Comprehensive Cancer Center	N/A	D (30)

Showing 51 to 95 of 95 assets

PreviousPage 2 of 2Next